Valuation GSK plc

Stocks

Market Closed - London S.E. 00:35:28 14/11/2026 HKT			5-day change	1st Jan Change
1,911.50 ^GBX	+0.55%		+1.14%	+4.77%

11-14	FTSE 100 closes at 3-month high as energy and defensive stocks rise	RE
11-14	European Stocks Close Mixed in Friday Trading; EU, Euro Area GDP Growth in Line With Projections	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,631	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.69%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	98,522	95,808	93,142
Change	-	-24.65%	-1.89%	-8.24%	28.83%	12.4%	-2.75%	-2.78%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	15.5x	12.4x	11.4x
PBR	5.34x	5.47x	4.4x	4.02x	4.51x	4.4x	4.26x	3.68x
PEG	-	0x	-0.2x	-0.4x	0x	-1.2x	0.5x	1.34x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.27x	2.17x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.91x	2.72x	2.56x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.55x	7.82x	7.4x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.52x	8.72x	8.12x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	20.6x	20.3x	15.9x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	4.85%	4.93%	6.3%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7479	0.7822
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.64%	3.91%	4.09%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.233	1.543	1.674
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	56.4%	48.5%	46.7%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,829	35,281	36,435
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,526	12,248	12,592
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,353	10,990	11,465
Net income ¹	4,385	14,956	4,928	2,575	5,716	4,918	6,109	6,668
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	21,891	19,177	16,511
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.12	19.12	19.12
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,008,939	-	-
Announcement Date	9/2/22	1/2/23	31/1/24	5/2/25	4/2/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GSK PLC	15.5x	2.91x	8.55x	3.64%	101B
ELI LILLY AND COMPANY	42.25x	14.3x	30.31x	0.47%	1,286B
JOHNSON & JOHNSON	41.82x	7.01x	19.73x	1.87%	688B
ABBVIE INC.	37.62x	8.63x	17.81x	2.34%	521B
ROCHE HOLDING AG	21.75x	5.27x	13.2x	2.48%	386B
MERCK & CO., INC.	104.88x	5.98x	25.49x	2.3%	364B
NOVARTIS AG	24x	5.82x	14.17x	2.73%	302B
ASTRAZENECA PLC	24.25x	4.85x	13.63x	1.8%	287B
AMGEN INC.	24.04x	7.38x	13.56x	2.17%	252B
GILEAD SCIENCES, INC.	-39.49x	7.32x	46.07x	1.96%	208B
Average	29.66x	6.95x	20.25x	2.18%	440B
Weighted average by Cap.	37.06x	8.82x	22.36x	1.72%